Considering the potential role of NMD in the antigen landscape, as its inhibition triggers tumor immunity by stabilization of PTC-containing neoantigens [14–17], we hypothesize that NMD function could be actively sequestered by the tumor to silence frameshift-derived neoantigens. The gene discussed is PLA1A; the disease is neoplasm.